A new “Dementia Trials Accelerator”, backed by GBP 20 million (EUR 24 million) of UK Government funding, has been launched to increase the number of people participating in dementia clinical trials in the UK from just 61 in 2021-22 to “tens of thousands”. Spearheaded by two national research institutes, the UK Dementia Research Institute and the Health Data Research UK, the Dementia Trials Accelerator will tackle the historically low numbers of people enrolled into dementia trials in the UK. The initiative, which is supported by the Government’s Dame Barbara Windsor Dementia Goals programme (formerly known as the Dame Barbara Windsor Dementia Mission), aims to rapidly identify a large group of people who are at risk of or diagnosed with early-stage dementia. The Dementia Trials Accelerator is still in development and is not yet recruiting participants.
You can read the full news story, here: https://ukdri.ac.uk/news-and-events/new-20m-dementia-trials-accelerator-will-increase-number-of-dementia-trial-participants-to-tens-of-thousands
For updates about the Dementia Trials Accelerator, please visit: https://ukdri.ac.uk/partners/dementia-trials-accelerator-dta